日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

吡托布替尼与伊布替尼治疗初治及复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的比较

Woyach, Jennifer A; Qiu, Lugui; Grosicki, Sebastian; Wrobel, Tomasz; Capra, Marcelo; Czyz, Jaroslaw; Yi, Shuhua; Eom, Ki-Seong; Panovská, Anna; Jurczak, Wojciech; Laribi, Kamel; Jacobasch, Lutz; Baker, Ross; Agajanian, Richy; Berkovits, Alejandro; Özcan, Muhit; Lepretre, Stéphane; Coombs, Catherine C; Cramer, Paula; Lewis, Katharine L; Hill, Marisa; Bao, Katherine; Bian, Yuanyuan; De Batista Ribeiro, Silvia Ramalho; Bhandari, Naleen Raj; Ruppert, Amy S; Leow, Ching Ching; Wierda, William G

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

复发/难治性慢性淋巴细胞白血病对吡托布替尼的反应和耐药性的基因组决定因素

Brown, Jennifer R; Nguyen, Bastien; Desikan, Sai Prasad; Won, Helen; Tantawy, Shady I; McNeely, Samuel C; Marella, Narasimha; Randeria, Hetal S; Hanson, Lauren M; Parker, Andrew; Botelho, Salomé Calado; Woyach, Jennifer A; Patel, Krish; Tam, Constantine S; Eyre, Toby A; Cheah, Chan Y; Shah, Nirav N; Ghia, Paolo; Jurczak, Wojciech; Balbas, Minna; Nair, Binoj; Abada, Paolo; Wang, Chunxiao; Wang, Denise; Roeker, Lindsey E; Gandhi, Varsha; Wierda, William G

Is CLL curable?

慢性淋巴细胞白血病可以治愈吗?

Jain, Nitin; Ferrajoli, Alessandra; O'Brien, Susan; Wierda, William

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome

POT1肿瘤易感综合征的临床、遗传和家族特征

DiNardo, Courtney D; Croden, Jennifer; Abdel-Salam, Hiam M; Kadia, Tapan; Molica, Matteo; Bazinet, Alexandre; Bose, Prithviraj; Maiti, Abhishek; Haddad, Fadi; Burger, Jan; Kantarjian, Hagop; Wierda, William; Jain, Nitin; Ferrajoli, Alessandra

Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemia

伊他替尼联合阿仑单抗治疗T细胞前淋巴细胞白血病患者的1B期试点研究

Kadia, Tapan M; Jain, Akhil; Rausch, Caitlin R; Bataller, Alex; Ravandi, Farhad; Jabbour, Elias; Qiao, Wei; Borthakur, Gautam; Short, Nicholas; Montalban-Bravo, Guillermo; Quesada, Andres E; Burger, Jan; Ferrajoli, Alessandra; Wierda, William; Hosing, Chitra; Kantarjian, Hagop

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN

在ELEVATE-TN研究的6年随访结果中,阿卡替尼联合奥妥珠单抗治疗与化疗免疫疗法相比,可改善初治慢性淋巴细胞白血病患者的生存期。

Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Patel, Krish; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Hughes, Marie; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Follows, George; Walker, Patricia; Ghia, Paolo; Janssens, Ann; Byrd, John C; Ferrant, Emmanuelle; Ferrajoli, Alessandra; Wierda, William G; Wachira, Catherine Wangui; Suterwala, Batul T; Miranda, Paulo; Munugalavadla, Veerendra; Wun, Chuan-Chuan; Woyach, Jennifer A

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

ZUMA-3 研究对接受 brexucabtagene autoleucel 治疗的复发或难治性 B 细胞急性淋巴细胞白血病成年患者进行了为期三年的分析

Shah, Bijal D; Cassaday, Ryan D; Park, Jae H; Houot, Roch; Logan, Aaron C; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; O'Dwyer, Kristen M; Tzachanis, Dimitrios; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Damico Khalid, Rita; Ghobadi, Armin; Oluwole, Olalekan O

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

更正:ELEVATE-TN 研究 4 年随访结果显示,在初治慢性淋巴细胞白血病患者中,阿卡替尼联合或不联合奥妥珠单抗与奥妥珠单抗联合苯丁酸氮芥的疗效和安全性。

Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Paolo; Janssens, Ann; Cymbalista, Florence; Woyach, Jennifer A; Ferrant, Emmanuelle; Wierda, William G; Munugalavadla, Veerendra; Yu, Ting; Wang, Min Hui; Byrd, John C

CLL cell-derived exosomes alter the immune and hematopoietic systems

慢性淋巴细胞白血病细胞来源的外泌体改变免疫系统和造血系统。

Veletic, Ivo; Harris, David M; Rozovski, Uri; Bertilaccio, Maria Teresa S; Calin, George A; Takahashi, Koichi; Li, Ping; Liu, Zhiming; Manshouri, Taghi; Drula, Rares-Constantin; Furudate, Ken; Muftuoglu, Muharrem; Hossain, Anwar; Wierda, William G; Keating, Michael J; Estrov, Zeev

VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial

VEN联合10天DEC治疗新诊断的老年或复发/难治性急性髓系白血病和高危骨髓增生异常综合征:一项II期试验的长期随访

Swaminathan, Mahesh; DiNardo, Courtney D; Maiti, Abhishek; Pemmaraju, Naveen; Ohanian, Maro; Daver, Navel G; Garcia-Manero, Guillermo; Issa, Ghayas C; Borthakur, Gautam; Ravandi, Farhad; Montalban-Bravo, Guillermo; Kadia, Tapan M; Alvarado, Yesid; Jabbour, Elias J; Short, Nicholas J; Wierda, William G; Jain, Nitin; Kornblau, Steven M; Masarova, Lucia; Pierce, Sherry A; Qiao, Wei; Ning, Jing; Kantarjian, Hagop; Konopleva, Marina Y